Seuraa
Frédéric Bost
Frédéric Bost
INSERM U1065, Université Côte d'Azur
Vahvistettu sähköpostiosoite verkkotunnuksessa unice.fr
Nimike
Viittaukset
Viittaukset
Vuosi
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13488*2021
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
IB Sahra, K Laurent, A Loubat, S Giorgetti-Peraldi, P Colosetti, P Auberger, ...
Oncogene 27 (25), 3576-3586, 2008
10872008
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
I Ben Sahra, C Regazzetti, G Robert, K Laurent, Y Le Marchand-Brustel, ...
Cancer research 71 (13), 4366-4372, 2011
7072011
The role of MAPKs in adipocyte differentiation and obesity
F Bost, M Aouadi, L Caron, B Binétruy
Biochimie 87 (1), 51-56, 2005
6332005
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells
I Ben Sahra, K Laurent, S Giuliano, F Larbret, G Ponzio, P Gounon, ...
Cancer research 70 (6), 2465-2475, 2010
6212010
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
I Ben Sahra, Y Le Marchand-Brustel, JF Tanti, F Bost
Molecular cancer therapeutics 9 (5), 1092-1099, 2010
6112010
The extracellular signal–regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis
F Bost, M Aouadi, L Caron, P Even, N Belmonte, M Prot, C Dani, ...
Diabetes 54 (2), 402-411, 2005
4112005
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
YY Wang, C Attané, D Milhas, B Dirat, S Dauvillier, A Guerard, J Gilhodes, ...
JCI insight 2 (4), 2017
3872017
Hypoxia decreases insulin signaling pathways in adipocytes
C Regazzetti, P Peraldi, T Grémeaux, R Najem-Lendom, I Ben-Sahra, ...
Diabetes 58 (1), 95-103, 2009
3322009
The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin
O Potapova, A Haghighi, F Bost, C Liu, MJ Birrer, R Gjerset, D Mercola
Journal of Biological Chemistry 272 (22), 14041-14044, 1997
2851997
Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage
F Bost, L Caron, I Marchetti, C Dani, YLE MARCHAND-BRUSTEL, ...
Biochemical Journal 361 (3), 621-627, 2002
2502002
Inter‐α‐trypsin inhibitor proteoglycan family: A group of proteins binding and stabilizing the extracellular matrix
F Bost, M Diarra‐Mehrpour, JP Martin
European Journal of Biochemistry 252 (3), 339-346, 1998
2421998
Role of MAPKs in development and differentiation: lessons from knockout mice
M Aouadi, B Binetruy, L Caron, Y Le Marchand-Brustel, F Bost
Biochimie 88 (9), 1091-1098, 2006
2222006
Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
Y Li, B Lin, A Agadir, R Liu, MI Dawson, JC Reed, JA Fontana, F Bost, ...
Molecular and cellular biology 18 (8), 4719-4731, 1998
2151998
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans
C Dray, C Debard, J Jager, E Disse, D Daviaud, P Martin, C Attané, ...
American journal of physiology-endocrinology and metabolism 298 (6), E1161-E1169, 2010
2102010
Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages
M Aouadi, K Laurent, M Prot, Y Le Marchand-Brustel, B Binétruy, F Bost
Diabetes 55 (2), 281-289, 2006
2102006
The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
F Bost, R McKay, N Dean, D Mercola
Journal of Biological Chemistry 272 (52), 33422-33429, 1997
1981997
The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
F Bost, R McKay, M Bost, O Potapova, NM Dean, D Mercola
Molecular and cellular biology 19 (3), 1938-1949, 1999
1901999
Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death
I Ben-Sahra, B Dirat, K Laurent, A Puissant, P Auberger, A Budanov, ...
Cell Death & Differentiation 20 (4), 611-619, 2013
1632013
The metabolic modulator PGC-1α in cancer
F Bost, L Kaminski
American journal of cancer research 9 (2), 198, 2019
1602019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20